Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,088 across all filing types
Latest filing 2021-04-20 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
关于变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about a change in accounting policy related to the adoption of a new lease accounting standard issued by the Ministry of Finance of China. It explains the reasons for the change, the differences between the old and new policies, the effective date, and the impact on financial statements. The document is relatively short (1550 characters) and does not contain actual financial statements or detailed financial data. It is a regulatory announcement about accounting policy changes rather than a full financial report or audit report. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance disclosure about accounting policy changes without substantive financial data or audit opinions.
2021-04-20 Chinese
关于举行2020年度网上业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is a short announcement (746 characters) about holding an online performance explanation meeting (业绩说明会) for the 2020 fiscal year. It references that the 2020 annual report has already been disclosed on April 13, 2021, and this announcement is to invite investors to participate in the online meeting on April 23, 2021. The document does not contain actual financial data or detailed report content but serves as a notice for the event. According to the 'MENU VS MEAL' rule, this is an announcement related to a meeting discussing the annual results, not the annual report itself. The document fits best into the category of Investor Presentation (IP) because it is about a detailed presentation for investors focusing on financials and company performance, even though it is an announcement of the meeting rather than the presentation itself. However, since it is specifically about an '业绩说明会' (performance explanation meeting), which is typically an investor presentation or earnings call presentation, the closest category is Investor Presentation (IP). Confidence is high given the clear context and content.
2021-04-20 Chinese
关于拟聘任公司2021年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed appointment of the company's audit firm for the 2021 fiscal year. It details the background of the audit firm, its qualifications, the audit team's members, and the approval process by the board, audit committee, and independent directors. The document does not contain any actual audit report or financial statements but is a notice about the intention to appoint the audit firm, pending shareholder approval. The document length is 3644 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits the category of Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or audit report itself. However, since it is an announcement about the appointment of the audit firm rather than the audit report or results, it is best classified as Audit Report / Information (AR) rather than Annual Report (10-K) or Report Publication Announcement (RPA). FY 2021
2021-04-12 Chinese
募集资金年度存放与使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is a detailed verification report (鉴证报告) for the year 2020 concerning the company's raised funds (募集资金) storage and usage. It includes an auditor's opinion from a certified public accountant firm, references to regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and detailed financial data on the raised funds usage, balances, and project changes. The document is not a full annual report but a specialized audit/verification report focused on the management and use of raised capital. It is not a simple announcement or certification letter but contains substantive financial and operational data related to fundraising usage. Therefore, it fits the category of an Audit Report / Information (AR) as it is a standalone audit/verification report on a specific financial aspect (fundraising usage) for the fiscal year 2020. FY 2020
2021-04-12 Chinese
2020年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised by the company through a public stock issuance. It includes specifics on the amount raised, usage of funds, changes in investment projects, and compliance with regulatory requirements. The presence of detailed financial figures, project investment progress, and regulatory references (e.g., China Securities Regulatory Commission approval) indicates this is a specialized report on fundraising and capital usage. It is not a general annual report, earnings release, or management discussion. The document focuses on the status and use of raised capital, which aligns with the category 'Capital/Financing Update (CAP)'. The document length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2021-04-12 Chinese
2020年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the fiscal year 2020 by a company. It contains detailed descriptions of the company's internal control environment, control activities, evaluation criteria for internal control deficiencies, and a conclusion on the effectiveness of internal controls as of December 31, 2020. The document references compliance with laws and regulations related to internal control and corporate governance. It is a comprehensive report on internal control evaluation rather than a general annual report or financial statement. It does not appear to be an announcement or a brief summary but a full report on internal control self-assessment. This fits the category of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluation results, excluding full annual reports. The document length (12,699 characters) and content depth support this classification with high confidence. FY 2020
2021-04-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.